Aurobindo Pharma Ltd. NSE: AUROPHARMA | BSE: 524804

Slowing Down Stock

Download real time

1019.50 -5.50 (-0.54%)

Near 52W Low of ₹1010.00

560.8K

NSE+BSE Volume

NSE 02 Sep, 2025 2:22 PM (IST)

USFDA Observation

Aurobindo Pharma's API facility in Telangana gets Form 483 with 3 observations from the US FDA See details

Aurobindo Pharma Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Aurobindo Pharma Ltd. from all sources in a single place.

Is Aurobindo Pharma Ltd. worth buying?

1256 Votes:

Buy 80.25%

Sell 13.77%

Hold 5.97%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >